Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
IOA-244 is a Non-ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune Tolerance.
Johnson Z, Tarantelli C, Civanelli E, Cascione L, Spriano F, Fraser A, Shah P, Nomanbhoy T, Napoli S, Rinaldi A, Niewola-Staszkowska K, Lahn M, Perrin D, Wenes M, Migliorini D, Bertoni F, van der Veen L, Di Conza G. Johnson Z, et al. Among authors: cascione l. Cancer Res Commun. 2023 Apr 14;3(4):576-591. doi: 10.1158/2767-9764.CRC-22-0477. eCollection 2023 Apr. Cancer Res Commun. 2023. PMID: 37066023 Free PMC article.
Papillary Thyroid Carcinoma: Molecular Distinction by MicroRNA Profiling.
Galuppini F, Censi S, Merante Boschin I, Fassan M, Sbaraglia M, Valeri N, Hahne JC, Bertazza L, Munari G, Galasso M, Cascione L, Barollo S, Rugge M, Vianello F, Dei Tos AP, Mian C, Pennelli G. Galuppini F, et al. Among authors: cascione l. Front Endocrinol (Lausanne). 2022 Feb 23;13:834075. doi: 10.3389/fendo.2022.834075. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35282462 Free PMC article.
microRNA classifiers are powerful diagnostic/prognostic tools in ALK-, EGFR-, and KRAS-driven lung cancers.
Gasparini P, Cascione L, Landi L, Carasi S, Lovat F, Tibaldi C, Alì G, D'Incecco A, Minuti G, Chella A, Fontanini G, Fassan M, Cappuzzo F, Croce CM. Gasparini P, et al. Among authors: cascione l. Proc Natl Acad Sci U S A. 2015 Dec 1;112(48):14924-9. doi: 10.1073/pnas.1520329112. Epub 2015 Nov 16. Proc Natl Acad Sci U S A. 2015. PMID: 26627242 Free PMC article.
A Sleeping Beauty screen reveals NF-kB activation in CLL mouse model.
Zanesi N, Balatti V, Riordan J, Burch A, Rizzotto L, Palamarchuk A, Cascione L, Lagana A, Dupuy AJ, Croce CM, Pekarsky Y. Zanesi N, et al. Among authors: cascione l. Blood. 2013 May 23;121(21):4355-8. doi: 10.1182/blood-2013-02-486035. Epub 2013 Apr 16. Blood. 2013. PMID: 23591791 Free PMC article.
Trisomy 12 CLLs progress through NOTCH1 mutations.
Balatti V, Lerner S, Rizzotto L, Rassenti LZ, Bottoni A, Palamarchuk A, Cascione L, Alder H, Keating MJ, Kipps TJ, Pekarsky Y, Croce CM. Balatti V, et al. Among authors: cascione l. Leukemia. 2013 Mar;27(3):740-3. doi: 10.1038/leu.2012.239. Epub 2012 Aug 20. Leukemia. 2013. PMID: 22902365 Free PMC article. No abstract available.
Correction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation.
Pichiorri F, Palmieri D, De Luca L, Consiglio J, You J, Rocci A, Talabere T, Piovan C, Lagana A, Cascione L, Guan J, Gasparini P, Balatti V, Nuovo G, Coppola V, Hofmeister CC, Marcucci G, Byrd JC, Volinia S, Shapiro CL, Freitas MA, Croce CM. Pichiorri F, et al. Among authors: cascione l. J Exp Med. 2017 May 1;214(5):1557. doi: 10.1084/jem.2012095001172017c. Epub 2017 Jan 19. J Exp Med. 2017. PMID: 28104811 Free PMC article. No abstract available.
Retraction Note: EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers.
Garofalo M, Romano G, Di Leva G, Nuovo G, Jeon YJ, Ngankeu A, Sun J, Lovat F, Alder H, Condorelli G, Engelman JA, Ono M, Rho JK, Cascione L, Volinia S, Nephew KP, Croce CM. Garofalo M, et al. Among authors: cascione l. Nat Med. 2022 Nov;28(11):2436. doi: 10.1038/s41591-022-02044-2. Nat Med. 2022. PMID: 36195688 Free PMC article. No abstract available.
MicroRNA profiling of blastic plasmacytoid dendritic cell neoplasm and myeloid sarcoma.
Sapienza MR, Fuligni F, Melle F, Tabanelli V, Indio V, Laginestra MA, Motta G, Mazzara S, Cerroni L, Pileri A, Facchetti F, Paulli M, Cascione L, Laganà A, Berti E, Ferracin M, Agostinelli C, Sabattini E, Croce CM, Pileri SA. Sapienza MR, et al. Among authors: cascione l. Hematol Oncol. 2020 Dec;38(5):831-833. doi: 10.1002/hon.2782. Epub 2020 Aug 14. Hematol Oncol. 2020. PMID: 33405278 No abstract available.
124 results